➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Patent: 8,202,099

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,202,099
Title:Instructional system and method for learning reading
Abstract: A system for teaching reading to very young children and first-time English students provides and uses one or more sets of instructional alphabetic letters, double-consonant phonemes, a relatively larger group of three-letter words of only short-vowel sounds, a relatively smaller group of three- and four-letter words with long-vowel sounds, and specifically designed subsets and/or combinations thereof, where the separate letters and words in the set is fewer than 100. The words in the instructional set are particularly selected to avoid phonetic confusion, ease pronunciation, engage student interest, provide teaching leverage based on each subset, and accelerate learning. In one embodiment, a particular 48-word instructional word set is distributed onto eight, 3-D, instructional blocks in a manner that preserves the subset-based teaching method. In other embodiments, the system can be presented on flashcards, magnets, printing on clothing or wallpaper, and through instructional computer software (home, internet, or PDA).
Inventor(s): Lancaster; J. (James) Justin (Quechee, VT)
Application Number:11/966,930
Patent Claims:see list of patent claims

Details for Patent 8,202,099

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial 2027-01-03 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.